Last reviewed · How we verify

NCT03250312

The Effects of OMT on the Expression Patterns of Immune Cell Biomarkers

Terminated NA Last updated 13 January 2020
What this trial tests

NA trial testing The Osteopathic Manipulation in Osteopathic Manipulation in 40 participants. Terminated before completion.

Timeline
13 September 2017
Primary endpoint
15 November 2017
31 August 2019

Quick facts

Lead sponsorA.T. Still University of Health Sciences
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment40
Start date13 September 2017
Primary completion15 November 2017
Estimated completion31 August 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

A.T. Still University of Health Sciences

Who can join

Adults 20 to 55, any sex, with Osteopathic Manipulation or Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study intends to understand the effects of osteopathic manipulative treatment (OMT) on the expression patterns of 60 immune cell biomarkers in the peripheral blood mononuclear cells (PBMC) of each participant, before and after intervention - OMT or seated control. This study will utilize participants with a history of low back pain (LBP), and will identify and validate those immune cell biomarkers that change in most participants after OMT, by using the novel protein subcellular localization (PSL) microarray technology. This study intends to uncover the important immune cells affected by OMT techniques, therefore to uncover the molecular mechanisms of OMT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteopathic Manipulation

Currently open trials in the same condition.

Other A.T. Still University of Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03250312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing